Metabolic Solutions Development Company (United States)

About

Metabolic Solutions Development Company (MSDC) is a drug discovery and development company investigating new molecular targets and developing novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company's pipeline includes MSDC-0160 and CIRIUS MSDC-0602, insulin sensitizer programs targeting metabolic syndrome, type 2 diabetes, and neurodegeneration.

Product

Value proposition

Developing novel therapeutics to address metabolic diseases tied to age-related mitochondrial dysfunction, with a focus on insulin resistance and type 2 diabetes

Founders

• Jerry Colca — Co-founder
• Rolf Kletzien — Co-founder

Categories

Products

Key features

Technologies

Target conditions

Partnerships

Investors

News

• Company - GT Metabolic Solutions · 2024-07-17T19:49:22.000Z
• Melyssa Wagner · 2026-06-11T22:26:41.000Z
• GT Metabolic Solutions - 2026 Company Profile, Team, Funding & Competitors - Tracxn · 2023-06-26T12:17:56.000Z
• GT Metabolic™ Solutions, Inc., opens doors to new surgical platform as FDA grants De Novo marketing authorization to its novel magnet compression anastomosis technology · 2024-09-04T14:00:00.000Z
• Startup Nula Emerges to Advance a New Class of Medicines for Metabolic Disease - MedCity News · 2026-04-16T19:15:21.000Z
• Danforth Technology Company Launches New Startup Metablify - Danforth Technology Company · 2024-10-28T13:00:54.000Z

Browse related software

• Clinic software in MI
• Clinic software in Kalamazoo
• BioTech software
• Pharmaceuticals software
• Drug Discovery software
• All clinic software companies A–Z

More links